Es gab 50 kürzliche Insider-Transaktionen für Merck & Co., Inc. (MRK), darunter 33 Käufe und 16 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $16.03M und die gesamten Insider-Verkäufe auf $24.7M.
Bedeutende Insider mit kürzlicher Aktivität umfassen Glocer Thomas H, Coe Mary Ellen, Seidman Christine E. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — MRK
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2026-03-31 |
Glocer Thomas H |
Director |
RSU-Zuteilung |
405 |
- |
- |
108,293 |
| 2026-03-31 |
Coe Mary Ellen |
Director |
RSU-Zuteilung |
249 |
- |
- |
29,703 |
| 2026-03-31 |
Seidman Christine E |
Director |
RSU-Zuteilung |
68 |
- |
- |
19,238 |
| 2026-03-02 |
Foard Brian |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2026-02-12 |
Guindo Chirfi |
Chief Marketing Officer |
Informierter Verkauf |
10,000 |
$121.46 |
$1.21M |
60,615 |
| 2026-02-10 |
Li Dean Y |
Executive VP & President, Mrl |
Informierter Verkauf |
10,235 |
$117.52 |
$1.2M |
92,035 |
| 2026-02-09 |
Guindo Chirfi |
Chief Marketing Officer |
Informierter Verkauf |
10,000 |
$118.41 |
$1.18M |
70,615 |
| 2026-02-09 |
Zachary Jennifer |
EVP, General Counsel |
Optionsausübung (Verkauf) |
38,835 |
$87.10 |
$3.38M |
- |
| 2026-02-06 |
Deluca Richard R. |
EVP&pres, Merck Animal Heallth |
Informierter Verkauf |
37,685 |
$120.92 |
$4.56M |
160,174 |
| 2026-02-06 |
Williams David Michael |
EVP,chief Info&digital Officer |
Optionsausübung (Verkauf) |
5,000 |
$77.62 |
$388.1K |
4,600 |
| 2026-02-06 |
Oosthuizen Johannes Jacobus |
President, U.s. Market |
Informierter Verkauf |
15,000 |
$121.87 |
$1.83M |
21,197 |
| 2026-02-05 |
Guindo Chirfi |
Chief Marketing Officer |
Informierter Verkauf |
20,000 |
$121.88 |
$2.44M |
80,615 |
| 2026-02-04 |
Davis Robert M |
Chairman, CEO & President |
Informierter Verkauf |
32,462 |
$118.35 |
$3.84M |
443,602 |
| 2026-02-04 |
Li Dean Y |
Executive VP & President, Mrl |
Optionsausübung (Verkauf) |
15,087 |
$56.04 |
$845.48K |
- |
| 2026-02-04 |
Litchfield Caroline |
EVP & CFO |
Optionsausübung (Verkauf) |
41,997 |
$53.06 |
$2.23M |
- |
| 2026-02-04 |
Smart Dalton E. Iii |
SVP Fin. - Global Controller |
Optionsausübung (Verkauf) |
4,000 |
$62.07 |
$248.28K |
8,130 |
| 2026-01-26 |
Davis Robert M |
Chairman, CEO & President |
RSU-Zuteilung |
47,434 |
$107.40 |
$5.09M |
491,036 |
| 2026-01-26 |
Deluca Richard R. |
EVP&pres, Merck Animal Heallth |
RSU-Zuteilung |
12,264 |
$107.40 |
$1.32M |
197,859 |
| 2026-01-26 |
Chattopadhyay Sanat |
Exe V-p & Pres. Mmd |
RSU-Zuteilung |
13,880 |
$107.40 |
$1.49M |
13,880 |
| 2026-01-26 |
Guindo Chirfi |
Chief Marketing Officer |
RSU-Zuteilung |
9,865 |
$107.40 |
$1.06M |
100,615 |
| 2026-01-26 |
Zachary Jennifer |
EVP, General Counsel |
RSU-Zuteilung |
11,583 |
$107.40 |
$1.24M |
68,916 |
| 2026-01-26 |
Williams David Michael |
EVP,chief Info&digital Officer |
RSU-Zuteilung |
6,112 |
$107.40 |
$656.43K |
30,838 |
| 2026-01-26 |
Li Dean Y |
Executive VP & President, Mrl |
RSU-Zuteilung |
20,469 |
$107.40 |
$2.2M |
102,270 |
| 2026-01-26 |
Litchfield Caroline |
EVP & CFO |
RSU-Zuteilung |
15,852 |
$107.40 |
$1.7M |
90,192 |
| 2026-01-26 |
Oosthuizen Johannes Jacobus |
President, U.s. Market |
RSU-Zuteilung |
5,026 |
$107.40 |
$539.79K |
36,197 |
| 2026-01-26 |
Romanelli Joseph |
President, Human Health Int?l |
RSU-Zuteilung |
5,703 |
$107.40 |
$612.5K |
28,739 |
| 2026-01-26 |
Smart Dalton E. Iii |
SVP Fin. - Global Controller |
RSU-Zuteilung |
1,066 |
$107.40 |
$114.49K |
10,605 |
| 2025-12-31 |
Glocer Thomas H |
Director |
RSU-Zuteilung |
463 |
- |
- |
107,076 |
| 2025-12-31 |
Coe Mary Ellen |
Director |
RSU-Zuteilung |
285 |
- |
- |
29,232 |
| 2025-12-31 |
Seidman Christine E |
Director |
RSU-Zuteilung |
77 |
- |
- |
19,026 |
| 2025-11-10 |
Downing Cristal N |
Chief Comm. & Public Afrs Ofcr |
Informierter Verkauf |
7,085 |
$87.00 |
$616.4K |
- |
| 2025-11-03 |
Williams David Michael |
EVP,chief Info&digital Officer |
Informierter Verkauf |
8,614 |
$83.59 |
$720.04K |
24,578 |
| 2025-09-30 |
Glocer Thomas H |
Director |
RSU-Zuteilung |
581 |
- |
- |
105,646 |
| 2025-09-30 |
Coe Mary Ellen |
Director |
RSU-Zuteilung |
357 |
- |
- |
28,685 |
| 2025-09-30 |
Seidman Christine E |
Director |
RSU-Zuteilung |
97 |
- |
- |
18,776 |
| 2025-08-04 |
Guindo Chirfi |
Chief Marketing Officer |
Optionsausübung (Verkauf) |
36,903 |
- |
- |
- |
| 2025-08-04 |
Williams David Michael |
EVP,chief Info&digital Officer |
Optionsausübung (Verkauf) |
17,119 |
- |
- |
- |
| 2025-06-30 |
Glocer Thomas H |
Director |
RSU-Zuteilung |
616 |
- |
- |
104,041 |
| 2025-06-30 |
Coe Mary Ellen |
Director |
RSU-Zuteilung |
379 |
- |
- |
28,052 |
| 2025-06-30 |
Seidman Christine E |
Director |
RSU-Zuteilung |
103 |
- |
- |
18,496 |
| 2025-05-30 |
Russo Patricia F |
Director |
RSU-Zuteilung |
2,863 |
- |
- |
58,523 |
| 2025-05-30 |
Lavizzo-mourey Risa J |
Director |
RSU-Zuteilung |
2,863 |
- |
- |
15,367 |
| 2025-05-30 |
Glocer Thomas H |
Director |
RSU-Zuteilung |
2,863 |
- |
- |
103,425 |
| 2025-05-30 |
Baker Douglas M Jr |
Director |
RSU-Zuteilung |
2,863 |
- |
- |
9,344 |
| 2025-05-30 |
Craig Pamela J. |
Director |
RSU-Zuteilung |
2,863 |
- |
- |
31,991 |
| 2025-05-30 |
Thulin Inge G |
Director |
RSU-Zuteilung |
2,863 |
- |
- |
24,764 |
| 2025-05-30 |
Warden Kathy J |
Director |
RSU-Zuteilung |
2,863 |
- |
- |
15,504 |
| 2025-05-30 |
Rothman Paul |
Director |
RSU-Zuteilung |
2,863 |
- |
- |
31,991 |
| 2025-05-30 |
Coe Mary Ellen |
Director |
RSU-Zuteilung |
2,863 |
- |
- |
27,673 |
| 2025-05-30 |
Karsanbhai Surendralal Lanca |
Director |
RSU-Zuteilung |
2,863 |
- |
- |
3,421 |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall
